Examples of 'agalsidase beta' in a sentence
Meaning of "agalsidase beta"
agalsidase beta: a medication used to treat Fabry disease, a rare genetic disorder. It is an enzyme replacement therapy that helps breakdown certain fatty substances in the body
How to use "agalsidase beta" in a sentence
Basic
Advanced
agalsidase beta
Agalsidase beta may be excreted in milk.
There is a theoretical risk of decreased agalsidase beta activity.
Agalsidase beta clearance was not influenced by weight in this population.
After intravenous administration of agalsidase beta to adults with an infusion time of ca.
Fabrazyme is a medicine that contains the active substance agalsidase beta.
Renal elimination of agalsidase beta is considered to be a minor pathway for clearance.
There are no adequate data from the use of agalsidase beta in pregnant women.
Agalsidase beta is a protein and is expected to be metabolically degraded through peptide hydrolysis.
Substance agalsidase beta.
Fabrazyme 5 mg powder for concentrate for solution for infusion agalsidase beta.
It is not known how agalsidase beta affects pregnant or lactating women.
EPAR summary for the public agalsidase beta.
The subjects in the agalsidase beta group had higher levels of proteinuria at baseline.
Afterwards, all patients were treated with agalsidase beta for six months.
Purified agalsidase beta is a homodimeric glycoprotein with a molecular weight of approximately 100 kD.
See also
Study in patients switching from agalsidase beta to Replagal agalsidase alfa.
Fabrazyme is a solution for infusion ( drip into a vein ) containing the active substance agalsidase beta.
There were no effects of agalsidase beta on embryo-fetal development.
History of anaphylaxis or Type 1 hypersensitivity reaction to agalsidase beta.
As well, clearance of the agalsidase beta was reduced at higher dosages.
One vial of powder contains 35 mg of agalsidase beta.
The reconstituted solution contains 5 mg agalsidase beta per ml, and appears as a clear colourless solution.
Each vial of Fabrazyme contains a nominal value of 35 mg of agalsidase beta.
Based on its metabolism, agalsidase beta is an unlikely candidate for cytochrome P450 mediated drug-drug interactions.
Fabrazyme 35 mg powder for concentrate for solution for infusion agalsidase beta For intravenous use.
The scheme with agalsidase beta 1 mg / kg every 14 days offered the best efficacy-to-safety ratio.
These patients should be treated with caution when re-administering agalsidase beta See section 4.8.
Agalsidase beta ( Fabrazyme, manufactured by Genzyme ).
FD can be treated with a medication called agalsidase beta ( Fabrazyme ).
You'll also be interested in:
Examples of using Beta
Show more
Look at the beta function of quantum chromodynamics
Looks like some kind of beta technology
Beta mix solvent based tinting system
Examples of using Agalsidase
Show more
Agalsidase alfa is a highly purified preparation
There is a theoretical risk of decreased agalsidase alfa activity
Agalsidase beta may be excreted in milk
